188 related articles for article (PubMed ID: 25328920)
1. Osteonecrosis of the jaw in a patient on raloxifene: a case report.
Baur DA; Altay MA; Teich S; Schmitt Oswald M; Quereshy FA
Quintessence Int; 2015 May; 46(5):423-8. PubMed ID: 25328920
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene-induced osteonecrosis of the jaw (MRONJ) with no exposure to bisphosphonates: clinical and radiographic findings.
Bindakhil M; Shanti RM; Mupparapu M
Quintessence Int; 2021; 52(3):258-263. PubMed ID: 33491398
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population.
Lin TC; Yang CY; Kao Yang YH; Lin SJ
Osteoporos Int; 2014 May; 25(5):1503-11. PubMed ID: 24515577
[TBL] [Abstract][Full Text] [Related]
4. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.
Otto S; Schreyer C; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum S; Pautke C
J Craniomaxillofac Surg; 2012 Jun; 40(4):303-9. PubMed ID: 21676622
[TBL] [Abstract][Full Text] [Related]
6. A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis: A Nested Case-control Study.
Kwon JW; Park EJ; Jung SY; Sohn HS; Ryu H; Suh HS
J Dent Res; 2015 Sep; 94(9 Suppl):212S-9S. PubMed ID: 26001708
[TBL] [Abstract][Full Text] [Related]
7. The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene.
Chiu WY; Chien JY; Yang WS; Juang JM; Lee JJ; Tsai KS
J Clin Endocrinol Metab; 2014 Aug; 99(8):2729-35. PubMed ID: 24758181
[TBL] [Abstract][Full Text] [Related]
8. [Osteonecrosis of the jaw].
Drozdzowska B
Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
[TBL] [Abstract][Full Text] [Related]
9. Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
Eiken PA; Prieto-Alhambra D; Eastell R; Abrahamsen B
Osteoporos Int; 2017 Oct; 28(10):2921-2928. PubMed ID: 28664276
[TBL] [Abstract][Full Text] [Related]
10. Mandibular Osteonecrosis Associated With Raloxifene.
Pontes HAR; Souza LL; Uchôa DCC; Cerqueira JMM
J Craniofac Surg; 2018 May; 29(3):e257-e259. PubMed ID: 29303860
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates and osteonecrosis of the jaw: a retrospective study.
Murad OM; Arora S; Farag AF; Guber HA
Endocr Pract; 2007; 13(3):232-8. PubMed ID: 17599853
[TBL] [Abstract][Full Text] [Related]
12. The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects.
Chiu WY; Yang WS; Chien JY; Lee JJ; Tsai KS
PLoS One; 2018; 13(4):e0196419. PubMed ID: 29694412
[TBL] [Abstract][Full Text] [Related]
13. Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.
Loyson T; Van Cann T; Schöffski P; Clement PM; Bechter O; Spriet I; Coropciuc R; Politis C; Vandeweyer RO; Schoenaers J; Dumez H; Berteloot P; Neven P; Nackaerts K; Woei-A-Jin FJSH; Punie K; Wildiers H; Beuselinck B
Acta Clin Belg; 2018 Apr; 73(2):100-109. PubMed ID: 28693379
[TBL] [Abstract][Full Text] [Related]
14. Incidence of osteonecrosis of the jaw in Japanese osteoporosis patients taking minodronic acid.
Taguchi A; Uemura Y; Imai T; Tanaka S; Ohta H; Nakamura T; Orimo H; Sugimoto T; Soen S; Shiraki M;
J Bone Miner Metab; 2019 Sep; 37(5):886-892. PubMed ID: 30719580
[TBL] [Abstract][Full Text] [Related]
15. [Bisphosphonate and osteonecrosis of the jaw.].
Taguchi A
Clin Calcium; 2017; 27(2):225-231. PubMed ID: 28123124
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
[TBL] [Abstract][Full Text] [Related]
17. Dramatic osteonecrosis of the jaw associated with oral bisphosphonates, periodontitis, and dental implant removal.
Fernández Ayora A; Herion F; Rompen E; Reginster JY; Magremanne M; Lambert F
J Clin Periodontol; 2015 Feb; 42(2):190-5. PubMed ID: 25327450
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases.
Lee JJ; Cheng SJ; Wang YP; Jeng JH; Chiang CP; Kok SH
Head Neck; 2013 Jan; 35(1):E6-10. PubMed ID: 21523843
[TBL] [Abstract][Full Text] [Related]
19. [Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review].
Capsoni F
Reumatismo; 2008; 60(1):6-13. PubMed ID: 18432320
[TBL] [Abstract][Full Text] [Related]
20. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
